Showing results (101-110 of 169) with videos related to
Sort By:
Pageof 17
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|March 18, 2020
[Psoriasis in dupilumab-treated atopic dermatitis]S Senner, L Eicher, N Aszodi, et al.Hepatology (Baltimore, Md.)|August 26, 1999
Persistent activation of nuclear factor-kappaB in cultured rat hepatic stellate cells involves the induction of potentially novel Rel-like factors and prolonged changes in the expression of IkappaB family proteinsA M Elsharkawy, M C Wright, R T Hay, et al.The British Journal of Dermatology|May 12, 2007
Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trialS Weissenbacher, J Merkl, B Hildebrandt, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|April 23, 2022
Determinants of costs and benefits in atopic dermatitis routine care in GermanyN Mohr, M Augustin, L Zeervi, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|September 23, 2018
Pregnancy complications, treatment characteristics and birth outcomes in women with atopic dermatitis in DenmarkC R Hamann, A Egeberg, A Wollenberg, et al.The British Journal of Dermatology|December 21, 2000
Phenotyping of epidermal dendritic cells allows the differentiation between extrinsic and intrinsic forms of atopic dermatitisT Oppel, E Schuller, S Günther, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|March 2, 2021
Cost-of-illness of atopic dermatitis in Germany: data from dermatology routine careN Mohr, M Naatz, L Zeervi, et al.Biological Chemistry|October 11, 2001
Cyclo19,31[D-Cys19]-uPA19-31 is a potent competitive antagonist of the interaction of urokinase-type plasminogen activator with its receptor (CD87)V Magdolen, M Bürgle, N A de Prada, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|April 29, 2005
Position paper on diagnosis and treatment of atopic dermatitisU Darsow, J Lübbe, A Taïeb, et al.The British Journal of Dermatology|September 11, 2008
Economic evaluation of maintenance treatment with tacrolimus 0.1% ointment in adults with moderate to severe atopic dermatitisA Wollenberg, M K Sidhu, I Odeyemi, et al.Pageof 17